Literature DB >> 8679755

Results of lung volume reduction surgery in patients with emphysema. The Washington University Emphysema Surgery Group.

R D Yusen1, E P Trulock, M S Pohl, D G Biggar.   

Abstract

Between January 1993 and April 1995, 84 patients with emphysema underwent bilateral lung volume reduction surgery at Barnes Hospital, Fifty-three patients had completed 3 months; 37 patients, 6 months; and 19 patients, 1 year of follow-up. Significant improvement was observed in spirometric parameters, oxygenation, 6-minute walking distance, dyspnea indices, and quality-of-life scores. The average increases in FEV1 were 52%, 51%, and 61%, at 3,6, and 12 months, respectively, after surgery. The most common postoperative complication, prolonged ( > 7 days) chest tube drainage, was present in 63% of the cases, and the mean duration of hospitalization in the survivors was 15 days (range 5 to 49 days). This has been reduced to 11 days (median 7.5 days) for the subsequent 40 patients. Five postoperative deaths occurred, 2 in the first, 2 in the third, and 1 in the fifth postoperative month, respectively. The overall mortality in the 84 patients was 6%, and the actuarial survival at 1 year was 93%. Volume reduction surgery is a promising therapeutic option for patients with an appropriate pattern of emphysema. Improvement has been sustained for more than 1 year, and long-term follow-up is planned to ascertain the duration of the benefits.

Entities:  

Mesh:

Year:  1996        PMID: 8679755

Source DB:  PubMed          Journal:  Semin Thorac Cardiovasc Surg        ISSN: 1043-0679


  3 in total

1.  Different effects of lung volume reduction surgery and lobectomy on pulmonary circulation.

Authors:  M Haniuda; K Kubo; K Fujimoto; T Aoki; T Yamanda; J Amano
Journal:  Ann Surg       Date:  2000-01       Impact factor: 12.969

2.  Video-assisted thoracoscopic management for emphysema associated with contralateral destroyed lung.

Authors:  Xin Xu; Hanzhang Chen; Weiqiang Yin; Bing Wei; Dong Xiao; Jun Liu; Jianxing He
Journal:  J Thorac Dis       Date:  2013-04       Impact factor: 2.895

3.  Current dyspnea among long-term survivors of early-stage non-small cell lung cancer.

Authors:  Marc B Feinstein; Paul Krebs; Elliot J Coups; Bernard J Park; Richard M Steingart; Jack Burkhalter; Amy Logue; Jamie S Ostroff
Journal:  J Thorac Oncol       Date:  2010-08       Impact factor: 15.609

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.